Key result
Beta(3)-adrenoceptors are expressed in rabbit ventricular cardiomyocytes, and their stimulation decreases cardiomyocyte shortening and Ca2+ transients while shortening action potential duration.
Rabbit ventricular cardiomyocytes express functional beta(3)-adrenoceptors, making the rabbit a relevant model for studying their cardiac physiological roles.
Supports rabbit as model for beta(3)-adrenoceptor studies; leaves open human cardiac translation.
The beta(3)-adrenoceptors (beta(3)-ARs) have been identified and characterized in the human heart. Specific beta(3)-AR stimulation, unlike beta(1)-AR or beta(2)-AR stimulation, decreases cardiac contractility, partly via the G(i)-NO pathway. However, the precise role of cardiac beta(3)-ARs is not yet completely understood. Indeed, under normal conditions, the beta(3)-AR response is present only to a very low degree in rats and mice. Therefore, we evaluated whether beta(3)-ARs were present and functional in rabbit ventricular cardiomyocytes, and whether the rabbit could serve as a relevant model for the study of cardiac beta(3)-ARs. We used RT-PCR and Western blot to measure the beta(3)-AR transcripts and protein levels in rabbit ventricular cardiomyocytes. We also analysed the effect of beta(3)-AR stimulation using isoproterenol in combination with nadolol or SR 58611A on cardiomyocyte shortening, Ca(2+) transient, L-type Ca(2+) current (I(Ca,L)), delayed rectifier potassium current (I(Ks)) and action potential duration (APD). For the first time, we show that beta(3)-ARs are expressed in rabbit ventricular cardiomyocytes. The mRNA and protein sequences present a high homology to those of rat and human beta(3)-ARs. Furthermore, beta(3)-AR stimulation decreases cardiomyocyte shortening, Ca(2+) transient and I(Ca,L) amplitudes, via a G(i)-NO pathway. Importantly, beta(3)-AR stimulation enhances I(Ks) amplitude and shortens the APD. Taken together, our results indicate that the rabbit provides a relevant model, easily used in laboratories, to study the roles of cardiac beta(3)-ARs in physiological conditions.
No takes yet. Share an insight, caveat, or question.
Audigane et al. (2009) studied this question. beta(3)-AR stimulation (isoproterenol with nadolol or SR 58611A) was evaluated on beta(3)-AR expression and functional effects on cardiomyocytes. Beta(3)-adrenoceptors are expressed in rabbit ventricular cardiomyocytes, and their stimulation decreases cardiomyocyte shortening and Ca2+ transients while shortening action potential duration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: